COEP
NASDAQCoeptis Therapeutics Holdings Inc.
News25/Ratings0
News · 26 weeks540%
2026-03-012026-08-23
Mix2290d
- SEC Filings16(73%)
- Insider4(18%)
- Other2(9%)
Latest news
25 items- INSIDERSEC Form 4 filed by Chief Technology Officer Harris Jeffery Keeslar4 - Z Squared Inc. (0001759186) (Issuer)
- SECSEC Form S-8 filed by Coeptis Therapeutics Holdings Inc.S-8 - Z Squared Inc. (0001759186) (Filer)
- INSIDERChief Marketing Officer Schadel Christopher Ryan bought $3,920 worth of shares (1,000 units at $3.92) (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- SECSEC Form 10-Q filed by Coeptis Therapeutics Holdings Inc.10-Q - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form POSASR filed by Coeptis Therapeutics Holdings Inc.POSASR - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- INSIDERSEC Form 3 filed by new insider Harris Jeffery Keeslar3 - Z Squared Inc. (0001759186) (Issuer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form S-1 filed by Coeptis Therapeutics Holdings Inc.S-1 - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form EFFECT filed by Coeptis Therapeutics Holdings Inc.EFFECT - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form 424B3 filed by Coeptis Therapeutics Holdings Inc.424B3 - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form EFFECT filed by Coeptis Therapeutics Holdings Inc.EFFECT - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form POS AM filed by Coeptis Therapeutics Holdings Inc.POS AM - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form S-1 filed by Coeptis Therapeutics Holdings Inc.S-1 - Z Squared Inc. (0001759186) (Filer)
- INSIDERSEC Form 4 filed by Chief Marketing Officer Schadel Christopher Ryan4 - Z Squared Inc. (0001759186) (Issuer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECAmendment: Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Leadership Update8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- INSIDERLarge owner Bsg Series Cm, Llc disposed of 41,521,276 shares, closing all direct ownership in the company (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
COEP FAQ
5 questionsWhere does COEP stock trade?
Coeptis Therapeutics Holdings Inc. (COEP) is listed on NASDAQ.What sector and industry is COEP in?
Coeptis Therapeutics Holdings Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Coeptis Therapeutics Holdings Inc. go public?
Coeptis Therapeutics Holdings Inc. (COEP) completed its IPO in 2020.What companies are similar to COEP?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare COEP side-by-side with any of them on Quantisnow.How can I track COEP on Quantisnow?
Quantisnow aggregates Coeptis Therapeutics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COEP to receive live email and push alerts on every new disclosure.